misleading statements

Class action lawsuit filed against PomDoctor, Ltd. alleges fraudulent stock promotion, insider share dumping, and artificial trading that inflated prices during October-December 2025.

Law firm sues $GO over alleged failure to disclose rapid expansion problems, store closures, and asset write-downs between August 2025 and March 2026.

Hagens Berman files securities class action against $CORT after FDA rejection of lead drug and federal court patent loss, alleging concealment of clinical data warnings.

Apollo Global Management faces securities lawsuit over undisclosed Jeffrey Epstein ties revealed in investigative reports. Stock plummeted 15%, erasing $12B in market cap.

$ODD crashes 49% after disclosing 30% revenue decline tied to advertising partner algorithm changes and customer acquisition cost surge.

Richtech Robotics faces securities lawsuit alleging it misled investors about a Microsoft partnership that was merely a free prototyping program, not a commercial collaboration. Stock fell 20% after Microsoft's denial.

Power Solutions International faces class action lawsuit for allegedly concealing manufacturing inefficiencies and overstating data center demand. Shareholders have until May 19 to file claims.

Class action filed against $CIGL alleging fraudulent stock promotion scheme involving social media misinformation, insider dumping, and artificial trading during April-July 2025.

Ultragenyx faces class action alleging misrepresentation of setrusumab trial data using improper Phase II benchmarks. Investors from August 2023–December 2025 may be eligible to join the suit.

Class action lawsuit filed against $PLUG alleging false statements about DOE funding and hydrogen production between January and November 2025.

Class action lawsuit filed against $EOSE alleging securities fraud over undisclosed production delays, quality control issues, and inadequate guidance systems.

Rosen Law Firm alerts $INO investors of April 7, 2026 deadline to join class action over alleged false statements regarding manufacturing and regulatory prospects.

Plug Power faces class action lawsuit alleging false statements about DOE loans and hydrogen facilities. Investors have until April 3, 2026 to apply as lead plaintiffs.

Corcept Therapeutics faces securities fraud lawsuit after FDA rejected relacorilant application. Stock plummeted 50.4% following December rejection. Investor deadline April 21, 2026.

Pomerantz Law Firm files class action against Enphase Energy over alleged misstatements regarding inventory management and federal solar tax credit impacts. Stock fell 15.15% after weak Q3 guidance.

Schall Law Firm seeks $PSIX investors for class action over alleged false statements on data center business and manufacturing costs. Deadline: May 19, 2026.

Class action lawsuit filed against $COPT alleging executives misrepresented relacorilant clinical trial strength and FDA approval prospects, harming investors.

Mereo BioPharma faces class action lawsuit alleging misrepresentations regarding failed Phase 3 clinical trials, with lead plaintiff deadline April 6, 2026.

$ALIT shareholders have until May 15, 2026 to join securities fraud lawsuit over alleged misstatements. Stock fell 18.3% and 38.2% after guidance misses in August 2025 and February 2026.

Power Solutions International faces securities fraud class action over false data center claims. Stock plunged 48% following margin disclosures; lead plaintiff deadline set for May 19, 2026.